Device, Vascular, For Promoting Embolization
Main Filters
Device, Vascular, For Promoting Embolization
| IMBiotechnologies Ltd | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| Ekobi 501 | 0 | - | ||
| Ekobi 502 | 0 | - | ||
| Ekobi 503 | 0 | - | ||
| Ekobi 503L | 0 | - | ||
| Ekobi 503P | 0 | - | ||
| Ekobi 504 | 0 | - | ||
| Ekobi 505 | 0 | - | ||
| Shanghai Wallaby Medical Technologies Co., Inc. | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| 10USC04008 | 0 | - | ||
| 10USC04010 | 0 | - | ||
| 10USC04506 | 0 | - | ||
| 10USC04508 | 0 | - | ||
| 10USC04510 | 0 | - | ||
| 10USC05006 | 0 | - | ||
| 10USC05008 | 0 | - | ||
| 10USC05010 | 0 | - | ||
| 10USH01001 | 0 | - | ||
| 10USH01002 | 0 | - | ||
| 10USH01003 | 0 | - | ||
| 10USH01004 | 0 | - | ||
| 10USH01501 | 0 | - | ||
| 10USH01502 | 0 | - | ||
| 10USH01503 | 0 | - | ||
| 10USH01504 | 0 | - | ||
| 10USH02001 | 0 | - | ||
| 10USH02002 | 0 | - | ||
| 10USH02003 | 0 | - | ||
| 10USH02004 | 0 | - | ||
| 10USH02006 | 0 | - | ||
| 10USH02502 | 0 | - | ||
| 10USH02503 | 0 | - | ||
| 10USH02504 | 0 | - | ||
| 10USH02506 | 0 | - | ||
| 10USH03004 | 0 | - | ||
| 10USH03006 | 0 | - | ||
| 10USH03008 | 0 | - | ||
| 10USH03504 | 0 | - | ||
| 10USH03506 | 0 | - | ||
| 10USH03508 | 0 | - | ||
| 10USH04006 | 0 | - | ||
| 10USH04008 | 0 | - | ||
| 10USH04010 | 0 | - | ||
| 10USH05006 | 0 | - | ||
| 10USH05008 | 0 | - | ||
| 10USH05010 | 0 | - | ||
| Stryker Corporation | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| 542410 | 0 | - | ||
| 546113 | 0 | - | ||
| 546123 | 0 | - | ||
| 546133 | 0 | - | ||
| 546143 | 0 | - | ||
| 546154 | 0 | - | ||
5,525 Results
Results Per Page
- 50
- 100
- 250
Catalog #
AvailableQty
Starting At
Name
Company Name
Description
0
-
Occlusin 500
IMBiotechnologies Ltd
Occlusin 500 is a family of biodegradable dense microspheres which are available in a range of calibrated sizes. The poly-DL-lactic-co-glycolic acid (PLGA) microspheres are surface-coated with bovine collagen. Following injection, the collagen binds patient platelets resulting in a platelet-rich clot which occludes the vasculature. The microspheres slowly degrade and are removed from the body over 4-6 months.
0
-
Occlusin 500
IMBiotechnologies Ltd
Occlusin 500 is a family of biodegradable dense microspheres which are available in a range of calibrated sizes. The poly-DL-lactic-co-glycolic acid (PLGA) microspheres are surface-coated with bovine collagen. Following injection, the collagen binds patient platelets resulting in a platelet-rich clot which occludes the vasculature. The microspheres slowly degrade and are removed from the body over 4-6 months.
0
-
Occlusin 500
IMBiotechnologies Ltd
Occlusin 500 is a family of biodegradable dense microspheres which are available in a range of calibrated sizes. The poly-DL-lactic-co-glycolic acid (PLGA) microspheres are surface-coated with bovine collagen. Following injection, the collagen binds patient platelets resulting in a platelet-rich clot which occludes the vasculature. The microspheres slowly degrade and are removed from the body over 4-6 months.
0
-
Occlusin 500
IMBiotechnologies Ltd
Occlusin 500 is a family of biodegradable dense microspheres which are available in a range of calibrated sizes. The poly-DL-lactic-co-glycolic acid (PLGA) microspheres are surface-coated with bovine collagen. Following injection, the collagen binds patient platelets resulting in a platelet-rich clot which occludes the vasculature. The microspheres slowly degrade and are removed from the body over 4-6 months.
0
-
Occlusin 500
IMBiotechnologies Ltd
Occlusin 500 is a family of biodegradable, dense, hyperechoic microspheres, which are available in a range of calibrated sizes and marketed under the trade name Ekobi Embolization Microspheres. The microspheres consist of poly-DL-lactic-co-glycolic acid (PLGA) coated with bovine collagen. Following injection into the target vasculature, the collagen binds circulating platelets resulting in a platelet-rich clot which occludes the target vasculature. The microspheres slowly degrade and are removed from the body over 4-6 months.
0
-
Occlusin 500
IMBiotechnologies Ltd
Occlusin 500 is a family of biodegradable, dense, hyperechoic microspheres, which are available in a range of calibrated sizes and marketed under the trade name Ekobi Embolization Microspheres. The microspheres consist of poly-DL-lactic-co-glycolic acid (PLGA) coated with bovine collagen. Following injection into the target vasculature, the collagen binds circulating platelets resulting in a platelet-rich clot which occludes the target vasculature. The microspheres slowly degrade and are removed from the body over 4-6 months.
0
-
Occlusin 500
IMBiotechnologies Ltd
Occlusin 500 is a family of biodegradable, dense, hyperechoic microspheres, which are available in a range of calibrated sizes and marketed under the trade name Ekobi Embolization Microspheres. The microspheres consist of poly-DL-lactic-co-glycolic acid (PLGA) coated with bovine collagen. Following injection into the target vasculature, the collagen binds circulating platelets resulting in a platelet-rich clot which occludes the target vasculature. The microspheres slowly degrade and are removed from the body over 4-6 months.